Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126261731 | 12626173 | 1 | I | 20160721 | 20160805 | 20160805 | EXP | E2B_00556911 | CA-HQ SPECIALTY-CA-2016INT000690 | INTERCHEM | 55.00 | YR | F | Y | 0.00000 | 20160805 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126261731 | 12626173 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 0.357 MG, (2.5 MG,1 IN 1 W) | U | 201749 | .357 | MG | |||||||
| 126261731 | 12626173 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 7.142 MG, (50 MG,1 IN 1 W) | U | 0 | |||||||||
| 126261731 | 12626173 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 2.857 MG, (40 MG,1 IN 2 W) | U | 0 | 2.857 | MG | |||||||
| 126261731 | 12626173 | 4 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 2.857 MG, (20 MG,1 IN 1 W) | U | 0 | 2.857 | MG | |||||||
| 126261731 | 12626173 | 5 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | 0.285 MG/KG, (4 MG/KG,1 IN 2 W) | U | 0 | |||||||||
| 126261731 | 12626173 | 6 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | (2 G) | U | 0 | 2 | G |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126261731 | 12626173 | 1 | Rheumatoid arthritis |
| 126261731 | 12626173 | 2 | Rheumatoid arthritis |
| 126261731 | 12626173 | 3 | Rheumatoid arthritis |
| 126261731 | 12626173 | 4 | Rheumatoid arthritis |
| 126261731 | 12626173 | 5 | Rheumatoid arthritis |
| 126261731 | 12626173 | 6 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126261731 | 12626173 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126261731 | 12626173 | Alopecia | |
| 126261731 | 12626173 | Diarrhoea | |
| 126261731 | 12626173 | Drug ineffective | |
| 126261731 | 12626173 | Gastrointestinal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |